S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition

Experimental Cell Research

Volumn 318, Issue 8, 2012, Pages 936-943

  Liu, Weihua ^a,b   Lan, Tian ^c   Xie, Xi ^a   Huang, Kaipeng ^a   Peng, Jing ^a   Huang, Juan ^a   Shen, Xiaoyan ^a   Liu, Peiqing ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Fibronectin; Mitogen activated protein kinase signaling pathway; Sphingosine 1 phosphate; Sphingosine 1 phosphate receptors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; FIBRONECTIN; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HYPERGLYCEMIA; MALE; MESANGIUM CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84862791207     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.02.020     Document Type: Article

References (44)

1. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., Shan Z., Liu J., Tian H., Ji Q., Zhu D., Ge J., Lin L., Chen L., Guo X., Zhao Z., Li Q., Zhou Z., Shan G., He J. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010, 362:1090-1101.
2. Bolick D.T., Hatley M.E., Srinivasan S., Hedrick C.C., Nadler J.L. Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition. Endocrinology 2003, 144:5227-5231.
3. Liu W., Tang F., Deng Y., Li X., Lan T., Zhang X., Huang H., Liu P. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol. Cell. Biochem. 2009, 325:99-105.
4. Jia H., Qi X., Fang S., Jin Y., Han X., Wang Y., Wang A., Zhou H. Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression. Regul. Pept. 2009, 154:69-76.
5. Danesh F.R., Sadeghi M.M., Amro N., Philips C., Zeng L., Lin S., Sahai A., Kanwar Y.S. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8301-8305.
6. Guha M., Xu Z.G., Tung D., Lanting L., Natarajan R. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 2007, 21:3355-3368.
7. Wahab N., Cox D., Witherden A., Mason R.M. Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1). Biochem. J. 2007, 406:131-138.
8. Li X., Liu W., Wang Q., Liu P., Deng Y., Lan T., Zhang X., Qiu B., Ning H., Huang H. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol. Cell. Endocrinol. 2009, 307:157-162.
9. Giunti S., Barit D., Cooper M.E. Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med. 2006, 97:241-262.
10. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res. 2003, 47:401-407.
11. Wang J., Huang H., Liu P., Tang F., Qin J., Huang W., Chen F., Guo F., Liu W., Yang B. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats. Eur. J. Pharmacol. 2006, 553:297-303.
12. Spiegel S., Milstien S. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem. Soc. Trans. 2003, 31:1216-1219.
13. Ghosh T.K., Bian J., Gill D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 1990, 248:1653-1656.
14. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 1991, 114:155-167.
15. Olivera A., Rosenfeldt H.M., Bektas M., Wang F., Ishii I., Chun J., Milstien S., Spiegel S. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J. Biol. Chem. 2003, 278:46452-46460.
16. English D., Garcia J.G., Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 2001, 49:588-599.
17. Hla T., Lee M.J., Ancellin N., Paik J.H., Kluk M.J. Lysophospholipids-receptor revelations. Science 2001, 294:1875-1878.
18. Yang A.H., Ishii I., Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta 2002, 1582:197-203.
19. Takuwa Y., Okamoto H., Takuwa N., Gonda K., Sugimoto N., Sakurada S. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol. Cell. Endocrinol. 2001, 177:3-11.
20. Kluk M.J., Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta 2002, 1582:72-80.
21. Kluk M.J., Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ. Res. 2001, 89:496-502.
22. Kwon Y.G., Min J.K., Kim K.M., Lee D.J., Billiar T.R., Kim Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 2001, 276:10627-10633.
23. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 2000, 106:951-961.
24. Ohmori T., Yatomi Y., Osada M., Kazama F., Takafuta T., Ikeda H., Ozaki Y. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc. Res. 2003, 58:170-177.
25. Ryu Y., Takuwa N., Sugimoto N., Sakurada S., Usui S., Okamoto H., Matsui O., Takuwa Y. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ. Res. 2002, 90:325-332.
26. Lan T., Shen X., Liu P., Liu W., Xu S., Xie X., Jiang Q., Li W., Huang H. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. Arch. Biochem. Biophys. 2010, 502:112-120.
27. Liu W.H., Hei Z.Q., Nie H., Tang F.T., Huang H.Q., Li X.J., Deng Y.H., Chen S.R., Guo F.F., Huang W.G., Chen F.Y., Liu P.Q. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin. Med. J. (Engl.) 2008, 121:706-712.
28. Liu W., Zhang X., Liu P., Shen X., Lan T., Li W., Jiang Q., Xie X., Huang H. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur. J. Pharmacol. 2010, 638:150-155.
29. Liu W., Liu P., Tao S., Deng Y., Li X., Lan T., Zhang X., Guo F., Huang W., Chen F., Huang H., Zhou S.F. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch. Biochem. Biophys. 2008, 475:128-134.
30. Wu D., Peng F., Zhang B., Ingram A.J., Gao B., Krepinsky J.C. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Diabetologia 2007, 50:2008-2018.
31. Foidart J.B., Dechenne C.A., Mahieu P., Creutz C.E., de Mey J. Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogeneous cell lines. Investig. Cell Pathol. 1979, 2:15-26.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
33. Fukushima N., Ishii I., Contos J.J., Weiner J.A., Chun J. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 2001, 41:507-534.
34. Siehler S., Manning D.R. Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochim. Biophys. Acta 2002, 1582:94-99.
35. Takuwa Y. Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 2002, 1582:112-120.
36. Sugimoto N., Takuwa N., Okamoto H., Sakurada S., Takuwa Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol. Cell. Biol. 2003, 23:1534-1545.
37. Osada M., Yatomi Y., Ohmori T., Ikeda H., Ozaki Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun. 2002, 299:483-487.
38. Kawanabe T., Kawakami T., Yatomi Y., Shimada S., Soma Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J. Dermatol. Sci. 2007, 48:53-60.
39. Imasawa T., Kitamura H., Ohkawa R., Satoh Y., Miyashita A., Yatomi Y. Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy. Exp. Toxicol. Pathol. 2010, 62:53-60.
40. Wilmer W.A., Dixon C.L., Hebert C. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int. 2001, 60:858-871.
41. Chin B.Y., Mohsenin A., Li S.X., Choi A.M., Choi M.E. Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway. Am. J. Physiol. Renal Physiol. 2001, 280:F495-F504.
42. Ha H., Kim M.S., Park J., Huh J.Y., Huh K.H., Ahn H.J., Kim Y.S. Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition. Life Sci. 2006, 79:1561-1567.
43. Cuenda A., Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375.
44. Adhikary L., Chow F., Nikolic-Paterson D.J., Stambe C., Dowling J., Atkins R.C., Tesch G.H. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 2004, 47:1210-1222.